IMMUNIC, INC.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Power of Attorney (included on the signature page)
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Daniel Vitt and Glenn Whaley, and each of them, his or her true and lawful attorneys-in-fact, each with full power of substitution, for him or her in any and all capacities, to sign any amendments to this Annual Report on Form 10-K and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact or their substitute or substitutes may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ DANIEL VITT | Director, Chief Executive Officer (principal executive officer) | March 31, 2025 |
| Daniel Vitt | ||
| /s/ GLENN WHALEY | Chief Financial Officer (principal financial officer and principal accounting officer) | March 31, 2025 |
| Glenn Whaley | ||
| /s/ DUANE D. NASH | Executive Chairman | March 31, 2025 |
| Duane D. Nash | ||
| /s/ TAMAR HOWSON | Director | March 31, 2025 |
| Tamar Howson | ||
| /s/ JOERG NEERMANN | Director | March 31, 2025 |
| Joerg Neermann | ||
| /s/ RICHARD RUDICK | Director | March 31, 2025 |
| Richard Rudick | ||
| /s/ BARCLAY A. PHILLIPS | Director | March 31, 2025 |
| Barclay A. Phillips | ||
| /s/ SIMONA SKERJANEC | Director | March 31, 2025 |
| Maria Tornsen | ||
| /s/ MARIA TORNSEN | Director | March 31, 2025 |
| Maria Tornsen | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.